All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2025-P-1982
Requests that the FDA initiate rulemaking to switch hydroxychloroquine sulfate (HCQ) oral tablet products from prescription-only status to full over-the-counter status.
Documents
3
Comments
222
Key Dates
Comment Period OpensJun 27, 2025
Documents
| Type | Title | Status |
|---|---|---|
Other |
Comment Statistics
Total Comments
222
Keywords
CDER
Citizen Petition
America’s Frontline Doctors
initiate
rulemaking to switch hydroxychloroquine sulfate
oral tablet products from prescription
only status to full over the counter status
OPEN
Data from Regulations.gov